-
Pharmacology
-
- Enzymes
-
- ATPase & GTPase
- Carboxylase
- Caspase
- Cholinesterase
- Coenzymes
- Cyclase
- Cyclooxygenase
- Cytochrome P450
- Deacetylase
- Dehydrogenase
- Demethylase
- Hydrolase
- Hydroxylase
- Isomerase
- Kinase
-
- Adenosine kinase
- Akt
- AMP-kinase
- ATM
- CAM Kinase
- Casein kinase
- Cyclin-dependent kinase
- DNA-dependent Protein Kinase
- DYRK
- General
- Glycogen synthase kinase
- JAK
- MAPK
- mTOR
- Myosin light chain kinase
- PAK
- PI3-kinase
- PLK
- Protein Kinase A
- Protein Kinase C
- Protein Kinase G
- Rho kinase
- Sphingosine kinase
- Src
- Tyrosine Kinase
- Ligase
- Oxidases
- Oxygenase
- Phosphatase
- Phosphodiesterase
- Phospholipase & Lipase
- Polymerase
- Protease
- Reductase
- Secretase
- Synthetase & synthase
- Telomerase
- Transaminase
- Transferase
- Ion Channels
- Receptors & Transporters
-
- Adenosine
- Adrenoceptors
- Cannabinoid
- Catalytic Receptors
- Chemokine
- Dopamine
- Enzyme-Linked Receptors
- G protein-coupled estrogen
- GABA
- Glutamate
- Glycine
- Histamine
- Imidazoline
- Inositol triphosphate receptor
- Melatonin
- Muscarinic
- Nicotinic
- Nuclear Receptors
- Opioids
- Orphan 7-TM Receptors
- Peptide Receptors
-
- Angiotensin
- Apelin
- AXOR
- Bombesin
- Bradykinin
- CCK
- Endothelin
- Galanin
- Ghrelin
- Glucagon and Related Receptors
- LHRH
- Melanocortin
- Melanocyte Stimulating Hormone
- Motilin
- Neuromedin
- Neuropeptide FF/AF Receptors
- Neuropeptide S
- Neuropeptide Y
- Neurotensin
- Orexin
- Other
- Oxytocin
- PAR
- Secretin receptor
- Sensory Neuron Specific Receptor
- Somatostatin
- Substance P
- Tachykinins
- Vasopressin
- VIP
- Prostanoid
- Purinergics
- Serotonin
- Sigma
- Smoothened
- Sphingosine 1-Phosphate Receptors
- TGR5
- Toll-like Receptors
- Transporters
- - Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Epigenetics
- Extracellular matrix & cell adhesion
- Heat Shock Proteins
- Immunomodulators
- - Lipid signaling
- Signal transduction
- Stem Cells
-
Research Area
-
- Addiction
- Alzheimer's Disease
-
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Muscarinic
- Nicotinic
- Nitric oxide signaling
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Cancer
-
- Angiogenesis
- Apoptosis & cell cycle
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Epigenetics
- Extracellular matrix & cell adhesion
- Nuclear Receptors
- Signal transduction
- Depression
- Diabetes
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Heart disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Calcium
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Hypertension
-
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Obesity
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Serotonin
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
- Pain & inflammation
-
- Apoptosis & cell cycle
- Ca2+ signaling
- Cannabinoid
- Cytoskeleton & motor proteins
- GABA
- Glutamate
- Histamine
- Immunomodulators
- Nitric oxide signaling
- Opioids
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Parkinson's Disease
- Respiratory disease
-
- Adenosine
- Adrenoceptors
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Histamine
- Immunomodulators
- Muscarinic
- Nitric oxide signaling
- Other
- Peptide Receptors
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Coenzymes
- Cytokine and NF-κB signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Hedgehog signaling
- Immunomodulators
- Inositol & cAMP signaling
- Lipid signaling
- Nitric Oxide
- Stem Cells
- Sodium
- TRP
- Schizophrenia
- Stress / Anxiety
- Stroke
-
- Adenosine
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- Glutamate
- Immunomodulators
- Nitric oxide signaling
- Nuclear Receptors
- Other
- Potassium
- Signaling
-
- Amyloidogenesis
- Angiogenesis
- Apoptosis & cell cycle
- Ca2+ signaling
- Cytoskeleton & motor proteins
- DNA, RNA & protein synthesis
- Endocytosis & exocytosis
- Heat Shock Proteins
- Immunomodulators
- Lipid signaling
- Signal transduction
- Stem Cells
- Sodium
- TRP
We have 88 products in: Biochemicals >> Pharmacology >> Signaling >> Lipid signaling
Lipid signaling beginning with A - N |
Code | Name | Details | Image Abreview Publication |
|---|---|---|---|
| Selective COX-3 inhibitor Purity: > 98% |   | ||
| Important mediator in lipid metabolism Purity: > 98% | | ||
| EP1 and EP2 antagonist Purity: > 98% | | ||
| ω-6 polyunsaturated fatty acid, precursor of eicosanoids Purity: > 98% | | ||
| Natural triterpene; SREBP inhibitor Purity: > 98% | | ||
| Potent lipoxin A4 agonist Purity: > 99% | | ||
| Irreversible fatty acid synthase (FAS) inhibitor Purity: > 98% | | ||
| Prostacyclin analogue Purity: > 99% | | ||
| Potent, water soluble PGF2α analog Purity: > 99% | | ||
| Flavonoid. Lipooxygenase inhibitor. Anti-oxidant, anti-inflammatory agent. Purity: > 85% |  | ||
| Potent cyclo-oxygenase inhibitor Purity: > 99% | | ||
| Arachidonic acid metabolite Purity: > 99% | | ||
| Prostaglandin E1 (PGE1) metabolite Purity: > 98% | | ||
| 5(S),6(R)-Dihydroxyeicosa-7E,9E,11Z,14Z-tetraenoic acid (DiHETE) | Prostanoid Receptor Ligand; Eicosanoid Purity: > 99% | | |
| PLA2 inhibitor. Arachadonic acid analog. Purity: > 99% | | ||
| Competitive 15-hydroxy PGDH inhibitor. Synthetic derivative of prostaglandin E2. Purity: > 98% | | ||
| Methyl ester of cytochrome p450 product 5,6-EET Purity: > 98% | | ||
| Eicosanoid biosynthesis inhibitor Purity: > 98% | | ||
| Potent anti-oxidant flavonoid Purity: > 98% | | ||
| Endogenous cholesterol metabolite Purity: > 98% | | ||
| (±)-8,9-Epoxyeicosa-5Z,11Z,14Z-trienoic acid (8,9-epoxyeicosatrienoic acid) | Vasodilator agent. Eicosanoid. Purity: > 98% | | |
| Potent, selective methyltranferase inhibitor Purity: > 98% | | ||
| Inhibitor of SREBP (Sterol regulatory binding protein) transcription factors activation. Purity: > 98% | | ||
| Potent, irreversible, selective inhibitor of Ca2+ independent PLA2 Purity: > 98% | | ||
| Inhibitor of 5-lipoxygenase. Marker for activation of 5-lipoxygenase. Purity: > 98% | | ||
| Primary metabolite of eicosapentaenoic acid via the 15-lipoxygenase pathway Purity: > 98% | | ||
| Primary LTB4 metabolite Purity: > 99% | | ||
| 15(S)-Hydroxyeicosa-5Z,8Z,11Z,13E,17Z-pentaenoic acid (15(S)-HEPE) | 15-Lipoxygenase (15-LOX) metabolite Purity: > 98% | | |
| Enzymatic product of prostaglandin H2 Purity: > 99% | | ||
| Major peroxidation product of linoleic acid Purity: > 99% | | ||
| Non-selective COX inhibitor Purity: > 99% | | ||
| Cell-permeable PLA2 inhibitor Purity: > 98% | | ||
| Mitochondrial membrane-potential dye Purity: > 98% | | ||
| Potent, selective and irreversible inhibitor of monoacylglycerol lipase (MAGL) Purity: > 98% | | ||
| Highly potent COX1/2 inhibitor. Non-steroidal anti-inflammatory drug (NSAID). Purity: > 98% | | ||
| Active metabolite of prostacyclin (PGI2) Purity: > 99% | | ||
| Potent and selective EP4 receptor antagonist Purity: > 98% | | ||
| Potent thromboxane A2 receptor antagonist Purity: > 98% | | ||
| Potent leukotriene A4 hydrolase suicide inhibitor Purity: > 95% | | ||
| Potent chemoattractant. Leukotriene B4, BLT1 and BLT2 receptor agonist. Purity: > 99% | | ||
| Arachidonic acid metabolite. Cell-permeable immunomodulator. Purity: > 99% | | ||
| Mediator of inflammation Purity: > 98% | | ||
| Endogenous sleep-inducing lipid Purity: > 98% | | ||
| Potent HMG CoA reductase inhibitor Purity: > 98% | | ||
| Potent phospholipase A2 (PLA2) inhibitor. Agonist at RARα Purity: > 98% | | ||
| Antioxidant, anti-inflammatory, anti-cancer flavonoid Purity: > 99% | | ||
| PI3-kinase inhibitor Purity: > 99% |  | ||
| Potent, irreversible inhibitor of cystolic PLA2 (cPLA2) and Ca2+ independent PLA2 (iPLA2) Purity: > 98% | | ||
| Saponified analog of prostaglandin E1 methyl ester Purity: > 98% | | ||
| Antidyslipidemic agent Purity: > 98% | | ||
| Chromogenic substrate for PLA2 Purity: > 98% | | ||
| COX-2 inhibitor Purity: > 98% | |